Ferrer R L, Medrano J, Calpena R, Diego M, Graells M L, Molto M V, Pérez M T, Oliver M I, Salido G M
Department of Pathology and Surgery, School of Medicine, Miguel Hernandez University, Elche, Alicante, Spain.
Dig Dis Sci. 2001 Oct;46(10):2127-33. doi: 10.1023/a:1011994327575.
In order to study the effect of cholecystokinin and secretin on the endocrine function of the pancreas, we have developed an experimental model that we have applied to a total of 30 anesthetized rats stimulated with physiological or supraphysiological doses of cholecystokinin and secretin administered intravenously by continuous infusion. Our results show that the serum insulin concentration increases after the supramaximum dose of cholecystokinin is infused, while that of glucagon increases after the maximum dose of this hormone. In case of secretin, the serum glucagon level increases after the supramaximum dose, while that of insulin is not affected by any dose. We conclude that after infusion of physiological doses of cholecystokinin, the pancreatic secretion of glucagon is modified but not that of insulin, while secretin has no effect on the endocrine pancreatic secretion of either insulin or glucagon upon the same conditions.
为了研究胆囊收缩素和促胰液素对胰腺内分泌功能的影响,我们建立了一个实验模型,并将其应用于30只麻醉大鼠,通过持续静脉输注给予生理剂量或超生理剂量的胆囊收缩素和促胰液素。我们的结果表明,在输注超最大剂量的胆囊收缩素后,血清胰岛素浓度升高,而在该激素最大剂量后,胰高血糖素浓度升高。对于促胰液素,在超最大剂量后血清胰高血糖素水平升高,而胰岛素水平不受任何剂量的影响。我们得出结论,在输注生理剂量的胆囊收缩素后,胰高血糖素的胰腺分泌发生改变,但胰岛素的分泌未改变,而在相同条件下,促胰液素对胰岛素或胰高血糖素的胰腺内分泌分泌均无影响。